MAPT and Cognitive impairment: Multiple experimental studies show that peripheral LPS induced neuroinflammation, accumulation of Aβ, tau pathology, and cognitive impairment in non-transgenic rodents (217–219) although variable Aβ and tau pathology is apparent in transgenic mouse models of AD after peripheral LPS treatment (220–224).